0000929638-25-003007.txt : 20250813 0000929638-25-003007.hdr.sgml : 20250813 20250813170812 ACCESSION NUMBER: 0000929638-25-003007 CONFORMED SUBMISSION TYPE: SCHEDULE 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20250813 DATE AS OF CHANGE: 20250813 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ABVC BIOPHARMA, INC. CENTRAL INDEX KEY: 0001173313 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 260014658 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-84759 FILM NUMBER: 251212777 BUSINESS ADDRESS: STREET 1: 44370 OLD WARM SPRINGS BLVD. CITY: FREMONT STATE: CA ZIP: 94538 BUSINESS PHONE: 510-668-0881 MAIL ADDRESS: STREET 1: 44370 OLD WARM SPRINGS BLVD. CITY: FREMONT STATE: CA ZIP: 94538 FORMER COMPANY: FORMER CONFORMED NAME: American BriVision (Holding) Corp DATE OF NAME CHANGE: 20160111 FORMER COMPANY: FORMER CONFORMED NAME: METU BRANDS, INC. DATE OF NAME CHANGE: 20150908 FORMER COMPANY: FORMER CONFORMED NAME: ECOLOGY COATINGS, INC. DATE OF NAME CHANGE: 20080821 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Lind Global Fund II LP CENTRAL INDEX KEY: 0001871665 ORGANIZATION NAME: EIN: 863914253 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G/A BUSINESS ADDRESS: STREET 1: 444 MADISON AVENUE STREET 2: 41ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 646-701-7428 MAIL ADDRESS: STREET 1: 444 MADISON AVENUE STREET 2: 41ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 SCHEDULE 13G/A 1 primary_doc.xml SCHEDULE 13G/A 0000929638-23-002183 0001871665 XXXXXXXX LIVE 4 Common Stock, par value $0.001 per share 06/30/2025 0001173313 ABVC BIOPHARMA, INC. 00091F304 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 Rule 13d-1(c) Lind Global Fund II LP b DE 557143 0 557143 0 557143 N 3.2 PN (1) The reporting person's ownership consists of (i) 0 shares of common stock, (ii) 500,000 warrants to purchase shares of common stock (the "B Warrants") and (iii) 57,143 shares of common stock issuable to the reporting person pursuant to convertible securities entered into between Lind Global Fund II and ABVC BioPharma, Inc. (the "Convertible Securities"). Lind Global Partners II LLC b DE 557143 0 557143 0 557143 N 3.2 OO (1) The reporting person's ownership consists of (i) 0 shares of common stock, (ii) 500,000 B Warrants and (iii) 57,143 shares of common stock issuable to the reporting person pursuant to the Convertible Securities. EASTON JEFF b X1 557143 0 557143 0 557143 N 3.2 IN (1) The reporting person's ownership consists of (i) 0 shares of common stock, (ii) 500,000 B Warrants and (iii) 57,143 shares of common stock issuable to the reporting person pursuant to the Convertible Securities. ABVC BIOPHARMA, INC. 44370 OLD WARM SPRINGS BLVD., FREMONT, California, 94538 This statement is filed by the following entities and individuals (collectively, referred to as the "Reporting Persons"): o Lind Global Fund II LP, a Delaware limited partnership; o Lind Global Partners II LLC, a Delaware limited liability company; and o Jeff Easton, an individual and a citizen of the United States of America. Lind Global Partners II LLC, the general partner of Lind Global Fund II LP, may be deemed to have sole voting and dispositive power with respect to the shares held by Lind Global Fund II LP. Jeff Easton, the managing member of Lind Global Partners II LLC, may be deemed to have sole voting and dispositive power with respect to the shares held by Lind Global Fund II LP. The address of the principal business office for each of the Reporting Persons is: 444 Madison Ave, Floor 41 New York, NY 10022 See Row 4 of cover page for each Reporting Person. Y See Row 9 of cover page for each Reporting Person. See Row 11 of cover page for each Reporting Person. See Row 5 of cover page for each Reporting Person. See Row 6 of cover page for each Reporting Person. See Row 7 of cover page for each Reporting Person. See Row 8 of cover page for each Reporting Person. N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Lind Global Fund II LP By: Lind Global Partners II LLC, its General Partner, By: /s/ Jeff Easton 08/13/2025 Lind Global Partners II LLC /s/ Jeff Easton 08/13/2025 EASTON JEFF /s/ Jeff Easton 08/13/2025